Mechanisms of Vascular Dysfunction in Cirrhosis

肝硬化血管功能障碍的机制

基本信息

  • 批准号:
    7806780
  • 负责人:
  • 金额:
    $ 0.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-28 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a 5-year training plan for a mentored physician scientist in Gastroenterology and Hepatology. The Principal Investigator is a junior faculty member in the Division of Gastroenterology and Hepatology at University of Maryland School of Medicine (UMSOM). Drs. Thomas Pallone and Jean-Pierre Raufman will co-mentor the Pi's scientific training. Dr. Pallone (Professor, Departments of Medicine and Physiology) is a renowned leader in microcirculation. Dr. Raufman (Chief, Division of Gastroenterology and Hepatology) has expertise in bile acid signaling. An Advisory Committee of established scientists/mentors will provide scientific and career guidance. The UMSOM provides an ideal training environment for the Pi's academic career development. The combination of mentoring, didactic coursework, unwavering institutional support and commitment will maximize the Pi's ability to launch a productive scientific career. The proposed study focuses on elucidating the mechanisms of vascular dysfunction in cirrhosis. The preliminary data indicates that (i) conjugated bile acids (BA) induce vasodilation in rodent aortae; (ii) BA-mediated vasodilation is endothelium-dependent and nitric oxide (NO)-mediated; (iii) M3 muscarinic receptor inhibition and ablation attenuates BA- and acetylcholine-mediated vasodilation. Our central hypothesis is that cholinergic stimulation of vascular endothelial cells mediates vascular dysfunction and systemic vasodilation in cirrhosis. The Specific Aims are (1) To define the role of M3R-dependent signaling in bile acid-mediated vasodilation; (2) To establish that bile acid-mediated changes in small mesenteric arterial tone mimic changes in aortic vascular tone; (3) To determine the mechanism whereby M3R contributes to vascular dysfunction in a mouse model of cirrhosis. Portal hypertension is a major cause of morbidity and mortality in advanced liver disease and vascular dysfunction contributes significantly to the progression of portal hypertension in this setting. The proposed complementary in vitro and in vivo approaches will help (a) determine the importance of cholinergic stimulation in the development of NO-mediated stress in EC, (b) elucidate molecular mechanisms of BA- mediated vasodilation and (c) determine the impact of M3R knockdown on vascular dysfunction in the animal model of experimental cirrhosis. This line of investigation will fill critical gaps in understanding the mechanisms of vascular dysfunction in cirrhosis and identify molecules for therapeutic targeting.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sandeep Khurana其他文献

Sandeep Khurana的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sandeep Khurana', 18)}}的其他基金

Mechanisms of Vascular Dysfunction in Cirrhosis
肝硬化血管功能障碍的机制
  • 批准号:
    8006669
  • 财政年份:
    2010
  • 资助金额:
    $ 0.05万
  • 项目类别:
Mechanisms of Vascular Dysfunction in Cirrhosis
肝硬化血管功能障碍的机制
  • 批准号:
    7509962
  • 财政年份:
    2008
  • 资助金额:
    $ 0.05万
  • 项目类别:
Mechanisms of Vascular Dysfunction in Cirrhosis
肝硬化血管功能障碍的机制
  • 批准号:
    8092751
  • 财政年份:
    2008
  • 资助金额:
    $ 0.05万
  • 项目类别:
Mechanisms of Vascular Dysfunction in Cirrhosis
肝硬化血管功能障碍的机制
  • 批准号:
    7882308
  • 财政年份:
    2008
  • 资助金额:
    $ 0.05万
  • 项目类别:
Mechanisms of Vascular Dysfunction in Cirrhosis
肝硬化血管功能障碍的机制
  • 批准号:
    7663269
  • 财政年份:
    2008
  • 资助金额:
    $ 0.05万
  • 项目类别:
Mechanisms of Vascular Dysfunction in Cirrhosis
肝硬化血管功能障碍的机制
  • 批准号:
    8293282
  • 财政年份:
    2008
  • 资助金额:
    $ 0.05万
  • 项目类别:

相似海外基金

Spatiotemporal dynamics of acetylcholine activity in adaptive behaviors and response patterns
适应性行为和反应模式中乙酰胆碱活性的时空动态
  • 批准号:
    24K10485
  • 财政年份:
    2024
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structural studies into human muscle nicotinic acetylcholine receptors
人体肌肉烟碱乙酰胆碱受体的结构研究
  • 批准号:
    MR/Y012623/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Research Grant
CRCNS: Acetylcholine and state-dependent neural network reorganization
CRCNS:乙酰胆碱和状态依赖的神经网络重组
  • 批准号:
    10830050
  • 财政年份:
    2023
  • 资助金额:
    $ 0.05万
  • 项目类别:
Study on biological significance of acetylcholine and the content in food resources
乙酰胆碱的生物学意义及其在食物资源中的含量研究
  • 批准号:
    23K05090
  • 财政年份:
    2023
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
alpha7 nicotinic acetylcholine receptor allosteric modulation and native structure
α7烟碱乙酰胆碱受体变构调节和天然结构
  • 批准号:
    10678472
  • 财政年份:
    2023
  • 资助金额:
    $ 0.05万
  • 项目类别:
Diurnal Variation in Acetylcholine Modulation of Dopamine Dynamics Following Chronic Cocaine Intake
慢性可卡因摄入后乙酰胆碱对多巴胺动力学调节的昼夜变化
  • 批准号:
    10679573
  • 财政年份:
    2023
  • 资助金额:
    $ 0.05万
  • 项目类别:
Differential Nicotinic Acetylcholine Receptor Modulation of Striatal Dopamine Release as a Mechanism Underlying Individual Differences in Drug Acquisition Rates
纹状体多巴胺释放的烟碱乙酰胆碱受体差异调节是药物获取率个体差异的机制
  • 批准号:
    10553611
  • 财政年份:
    2022
  • 资助金额:
    $ 0.05万
  • 项目类别:
Striatal Regulation of Cortical Acetylcholine Release
纹状体对皮质乙酰胆碱释放的调节
  • 批准号:
    10549320
  • 财政年份:
    2022
  • 资助金额:
    $ 0.05万
  • 项目类别:
Structural basis of nicotinic acetylcholine receptor gating and toxin inhibition
烟碱乙酰胆碱受体门控和毒素抑制的结构基础
  • 批准号:
    10848770
  • 财政年份:
    2022
  • 资助金额:
    $ 0.05万
  • 项目类别:
Mechanisms of nicotinic acetylcholine receptor modulation of cocaine reward
烟碱乙酰胆碱受体调节可卡因奖赏的机制
  • 批准号:
    10672207
  • 财政年份:
    2022
  • 资助金额:
    $ 0.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了